Functionally, although no target genes of the ZNF224/MED28 complex have yet been identified, Cho and colleagues provided evidence that the interaction of ZNF224 and MED28 prevents ZNF224 degradation following DNA damage and consequently enhances the proliferation and survival of breast cancer cells. This evidence concerns the gene MED28 and breast carcinoma.